User profiles for E. Stoelben

Erich Stoelben

Thoraxchirurgie
Verified email at kliniken-koeln.de
Cited by 11673

[HTML][HTML] Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

…, S Ansén, C Ludwig, W Engel-Riedel, E Stoelben… - Cell, 2012 - cell.com
Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, is responsible
for more than 500,000 deaths per year worldwide. Here, we report exome and genome …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, Z Wainer, P Russell, I Petersen, Y Chen, E Stoelben… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

…, R Buettner, K Ernestus, E Stoelben… - Science translational …, 2010 - science.org
… Buettner, KE, E. Stoelben, J. Wolf, and PN contributed critical tumor specimens and contributed
to the discussion of the data. SP reviewed tumor histology, analyzed the FISH data, and …

Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

…, H Groen, W Timens, H Sietsma, E Stoelben… - Cancer discovery, 2011 - AACR
Although genomically targeted therapies have improved outcomes for patients with lung
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…

Extracorporeal membrane oxygenation: evolving epidemiology and mortality

…, D Brodie, S Strassmann, E Stoelben… - Intensive care …, 2016 - Springer
Purpose The evolution of the epidemiology and mortality of extracorporeal membrane
oxygenation (ECMO) remains unclear. The present study investigates the evolving epidemiology …

Chest wall resection for lung cancer: indications and techniques

E Stoelben, C Ludwig - European journal of cardio-thoracic …, 2009 - academic.oup.com
Lung cancer invasion of the chest wall is not a common challenge and represents only about
5% of all patients resected for lung cancer. In T3N0M0 tumours, long-term survival reaches …

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

…, A Riviere, P Koralewski, JL Breton, E Stoelben… - The lancet …, 2011 - thelancet.com
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …

Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer

…, T Schumacher, M Mix, S Ruhland, E Stoelben… - European journal of …, 2004 - Springer
Purpose The purpose of this study was to evaluate the impact of [ 18 F]fluorodeoxy-d-glucose
positron emission tomography (FDG-PET) on the primary staging of patients with small-cell …

[HTML][HTML] Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

…, M Lund-Iversen, S Ansén, E Stoelben… - Nature …, 2014 - nature.com
Pulmonary carcinoids are rare neuroendocrine tumours of the lung. The molecular alterations
underlying the pathogenesis of these tumours have not been systematically studied so far. …

CD74–NRG1 Fusions in Lung Adenocarcinoma

…, C Becker, P Nürnberg, JM Heuckmann, E Stoelben… - Cancer discovery, 2014 - AACR
We discovered a novel somatic gene fusion, CD74–NRG1, by transcriptome sequencing of
25 lung adenocarcinomas of never smokers. By screening 102 lung adenocarcinomas …